Senior Clinical Research Associate (CRA II) – Remote

KCR Placement; Madrid; Hybrid; EUR 42,000 - 62,000; Full time

Benefits offered by this job

Competitive benefits

Job summary

ICON is a global healthcare intelligence and clinical research organisation focused on bringing new medicines to patients faster. We are seeking a CRA II/Senior to design, analyze, and monitor trials, contributing to data interpretation and trial advancement.

The role involves site visits, data integrity, and collaboration with investigators to ensure high-quality study conduct. Travel near 60% is expected, with a supportive, inclusive culture.

Qualifications

• Bachelor's degree in a scientific or healthcare field.
• Minimum of 2 years of experience as a Clinical Research Associate.
• Knowledge of clinical trial processes, regulations, and ICH-GCP guidelines.
• Strong organizational and communication skills with attention to detail.
• Ability to work independently and collaboratively in a fast-paced environment.
• Willingness to travel as required (approximately 60%)

Responsibilities

• Conduct site qualification, initiation, monitoring, and close-out visits for clinical trials.
• Ensure protocol compliance, data integrity, and patient safety throughout the trial process.
• Collaborate with investigators and site staff to facilitate smooth study conduct.
• Perform data review and resolution of queries to maintain high-quality clinical data.
• Contribute to the preparation and review of study documentation, including protocols and clinical study reports

Skills

Attention to detail

Strong communication

Organizational skills

Independent work

Willingness to travel

Education

Bachelor's degree in science or healthcare

Tools

ICH-GCP knowledge

Job description

ICON is a global healthcare intelligence and clinical research organisation focused on bringing new medicines to patients faster. We are seeking a CRA II/Senior to design, analyze, and monitor trials, contributing to data interpretation and trial advancement.

The role involves site visits, data integrity, and collaboration with investigators to ensure high-quality study conduct. Travel near 60% is expected, with a supportive, inclusive culture.